Theravance Biopharma's top three insider shareholders as of March 23, 2026 are Eli Samaha (TenPercentOwner, 9.51Mn shares), Rick E Winningham (Chief Executive Officer, 1.58Mn shares), Frank Pasqualone (Svp, Chief Business Officer, 429.78K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Eli Samaha | 0 | 9,511,150 | 09 Aug, 2024 | |
| Rick E Winningham | Chief Executive Officer | 1,576,094 | 0 | 24 Feb, 2026 |
| Frank Pasqualone | Svp, Chief Business Officer | 429,783 | 0 | 23 Nov, 2021 |
| Andrew A. Hindman | Svp, Chief Financial Officer | 384,714 | 0 | 22 Nov, 2022 |
| Kenneth R Pitzer | Svp, Prod Strat Comm Plng | 380,123 | 0 | 23 Feb, 2022 |
| Brett A. Grimaud | Svp, Gen Counsel And Secretary | 334,449 | 0 | 24 Feb, 2026 |
| Philip D Worboys | Svp, Research Transl Science | 330,752 | 0 | 23 Nov, 2021 |
| Aziz Sawaf | Svp Chief Financial Officer | 316,123 | 0 | 24 Feb, 2026 |
| Richard A Graham | Svp, Research Development | 314,915 | 0 | 22 Feb, 2024 |
| Rhonda Farnum | Svp, Comm Medical Affairs | 263,766 | 0 | 24 Feb, 2026 |
| Vijay Sabesan | Svp, Technical Operations | 235,524 | 0 | 23 Nov, 2021 |
| Rhonda Farnum | Svp, Comm Medical Affairs | 232,699 | 0 | 18 Mar, 2026 |
| Aine Miller | Svp, Dev Head Of Ire Office | 184,161 | 0 | 24 Feb, 2026 |
| Ann Brady | President, Tbil | 110,319 | 0 | 23 Feb, 2022 |
| William D Young | 78,010 | 0 | 28 Apr, 2022 | |
| Alsup Laurie Smaldone | 74,980 | 0 | 21 May, 2025 | |
| Donal O'Connor | 74,204 | 0 | 21 May, 2025 | |
| Susannah Gray | 42,137 | 0 | 21 May, 2025 | |
| Jeremy T Grant | 32,954 | 0 | 21 May, 2025 | |
| Rick E Winningham | Chief Executive Officer | 0 | 23,400 | 21 Nov, 2025 |
| Susan Molineaux | 9,828 | 0 | 29 Apr, 2021 | |
| George M Whitesides | 9,828 | 0 | 29 Apr, 2021 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 16 Mar, 2026 | Rhonda Farnum | Ordinary Shares | D | 7,767 | $13.92 | 255,999 | D | S |
| 16 Mar, 2026 | Rhonda Farnum | Ordinary Shares | D | 15,534 | $14.00 | 240,465 | D | S |
| 16 Mar, 2026 | Rhonda Farnum | Ordinary Shares | D | 7,766 | $13.92 | 232,699 | D | S |
| 20 Feb, 2026 | Rhonda Farnum | Ordinary Shares | D | 13,929 | $19.66 | 263,766 | D | F |
| 20 Feb, 2026 | Rick E Winningham | Ordinary Shares | D | 74,975 | $19.66 | 1,576,094 | D | F |
| 20 Feb, 2026 | Rhonda Farnum | Ordinary Shares | D | 13,929 | $19.66 | 263,766 | D | F |
| 20 Feb, 2026 | Aine Miller | Ordinary Shares | D | 16,851 | $19.66 | 184,161 | D | F |
| 20 Feb, 2026 | Brett A. Grimaud | Ordinary Shares | D | 20,833 | $19.66 | 334,449 | D | F |
| 20 Feb, 2026 | Aziz Sawaf | Ordinary Shares | D | 20,672 | $19.66 | 316,123 | D | F |
| 03 Dec, 2025 | Rhonda Farnum | Ordinary Shares | D | 7,767 | $18.75 | 300,995 | D | S |
| 03 Dec, 2025 | Rhonda Farnum | Ordinary Shares | D | 7,767 | $18.75 | 300,995 | D | S |
| 03 Dec, 2025 | Rhonda Farnum | Ordinary Shares | D | 7,766 | $18.75 | 293,229 | D | S |
| 03 Dec, 2025 | Rhonda Farnum | Ordinary Shares | D | 7,766 | $18.75 | 293,229 | D | S |
| 03 Dec, 2025 | Rhonda Farnum | Ordinary Shares | D | 15,534 | $18.75 | 277,695 | D | S |
| 03 Dec, 2025 | Rhonda Farnum | Ordinary Shares | D | 15,534 | $18.75 | 277,695 | D | S |
| 20 Nov, 2025 | Brett A. Grimaud | Ordinary Shares | D | 19,024 | $17.90 | 355,282 | D | F |
| 20 Nov, 2025 | Aine Miller | Ordinary Shares | D | 6,989 | $17.90 | 201,012 | D | F |
| 20 Nov, 2025 | Aziz Sawaf | Ordinary Shares | D | 18,627 | $17.90 | 336,795 | D | F |
| 20 Nov, 2025 | Rhonda Farnum | Ordinary Shares | D | 9,060 | $17.90 | 308,762 | D | F |
| 20 Nov, 2025 | Rhonda Farnum | Ordinary Shares | D | 9,060 | $17.90 | 308,762 | D | F |